[1]
Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ. Principles of neural science: McGraw-hill New York; 2000
[2]
Markowitsch HJ. Diencephalic amnesia: A reorientation towards tracts? Brain Res Rev 1988; 13: 351-70.
[3]
Eichenbaum H, Cohen NJ. From conditioning to conscious recollection: Memory systems of the brain: Oxford University Press on Demand; 2004
[4]
White NM, McDonald RJ. Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 2002; 77: 125-84.
[5]
Ameen N, Shafi S. Various models for screening of memory enhancing drugs World J Pharm Sci 4: 387-94
[6]
Paulsen JS. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 2011; 11: 474.
[7]
Zlomuzica A, Dere D, Binder S, De Souza Silva MA, Huston JP, Dere E. Neuronal histamine and cognitive symptoms in Alzheimer’s disease. Neuropharmacology 2016; 106: 135-45.
[8]
Aarsland D. Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies. Parkinsonism Relat Disord 2016; 22 Suppl 1: S144-8.
[9]
Carroll ME, Overmier J. Animal research and human health: Advancing human welfare through behavioral science. American Psychological Association 2001.
[10]
Squire LR, Cohen NJ, Zouzounis JA. Preserved memory in retrograde amnesia: Sparing of a recently acquired skill. Neuropsychologia 1984; 22: 145-52.
[11]
Schacter DL, Buckner RL. Priming and the brain. Neuron 1998; 20: 185-95.
[12]
Izquierdo LA, Barros DM, Vianna MR, Coitinho A, de Silva TD, Choi H, et al. Molecular pharmacological dissection of short-and long-term memory. Cell Mol Neurobiol 2002; 22: 269-87.
[13]
Bandura A. Human agency in social cognitive theory. Am Psychol 1989; 44: 1175.
[14]
Anisman H. Aversively motivated behavior as a tool in psychopharmacologic analysis Psychopharmacology of aversively motivated behavior. Springer 1978; pp. 1-62.
[15]
Netto CA, Izquierdo I. On how passive is inhibitory avoidance. Behav Neural Biol 1985; 43: 327-30.
[16]
Joshi H, Parle M. Effects of piperine on memory and behavior mediated via monoamine neurotransmiters. J Traditional Med 2005; 22: 39-43.
[17]
Parle M, Dhingra D, Kulkarni S. Improvement of mouse memory by Myristica fragrans seeds. J Med Food 2004; 7: 157-61.
[18]
Parle M, Vasudevan M, Singh N. Swim everyday to keep dementia away. J Sports Sci Med 2005; 4: 37.
[19]
Vogel HG. Drug discovery and evaluation: Pharmacological assays. Springer Science & Business Media 2002.
[20]
Mali A, Shenoy P, Bandawane D, Nipate S, Chaudhari P. Screening of nootropics: an overview on preclinical evaluation techniques. Int J Pharm 2012; 2: 159-80.
[21]
Ogren S, Stiedl O. Passive Avoidance 2010.
[22]
Narwal S, Saini D, Kumari K, et al. Behavior & pharmacological animal models for the evaluation of learning & memory condition. Indo Global J Pharm Sci 2012; 2: 121-9.
[23]
Zameer S, Vohora D. Effect of aromatase inhibitors on learning and memory and modulation of hippocampal dickkopf-1 and sclerostin in female mice. Pharmacol Rep 2017; 9(6): 1300-7.
[24]
Aguilar MA, Miñarro J, Simón VM. Morphine potentiates the impairing effects of neuroleptics on two-way active conditioned avoidance response in male mice. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 225-37.
[25]
Vaglenova J, Birru S, Pandiella NM, Breese CR. An assessment of the long-term developmental and behavioral teratogenicity of prenatal nicotine exposure. Behav Brain Res 2004; 150: 159-70.
[26]
Netto CA, Valente JT, Borges-Sobrinho JB, Lasevitz J, Tomaz CA. Reversal of retrieval impairment caused by retroactive interference on a two-way active avoidance task in rats. Behav Neural Biol 1991; 55: 114-22.
[27]
Quillfeldt JA. Behavioral methods to study learning and memory in rats 2006. 21: 1-42
[28]
Aspide R, Fresiello A, De Filippis G, Carnevale UG, Sadile A. Non-selective attention in a rat model of hyperactivity and attention deficit: Subchronic methylphenydate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev 2000; 24: 59-71.
[29]
Gupta A, Upmanyu N, Vashist H. Various animal models to check learning and memory: A review. Int J Pharm Sci Res 2012; 4(3): 1-5.
[30]
De Melo LCS, Cruz AP, Valentim SJR, Marinho AR, Mendonça JB, Nakamura-Palacios EMΔ. 9-THC administered into the medial prefrontal cortex disrupts the spatial working memory. Psychopharmacol 2005; 183: 54-64.
[31]
Vorhees CV, Williams MT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1: 848.
[32]
Fitzgerald LW, Dokla CP. Morris water task impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity. Brain Res 1989; 505: 246-50.
[33]
Packard MG, Teather LA. Double dissociation of hippocampal and dorsal-striatal memory systems by posttraining intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav Neurosci 1997; 111: 543-51.
[34]
Bannerman DM, Chapman PF, Kelly PA, Butcher SP, Morris RG. Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci 1994; 14: 7404-14.
[35]
Terry Jr AV. Spatial navigation (water maze) tasks. Method Behav Neurosci 2000; 2. PMID: 21204326
[36]
Quillfeldt JA. Behavioral methods to study learning and memory in ratsRodent model as tools in ethical biomedical research: Springer; 2016; 12: 271-311
[37]
Dhingra D, Parle M, Kulkarni S. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 2004; 91: 361-5.
[38]
Sharma M, Gupta Y. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 2002; 71: 2489-98.
[39]
Antunes M, Biala G. The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cogn Process 2012; 13: 93-110.
[40]
Kaundal M, Akhtar M, Deshmukh R. Lupeol isolated from betula alnoides ameliorates amyloid beta induced neuronal damage via targeting various pathological events and alteration in neurotransmitter levels in rat’s brain. J Neurol Neurosci 2017; 8.
[41]
Olton DS, Becker JT, Handelmann GE. Hippocampus, space, and memory. Behav Brain Sci 1979; 2: 313-22.
[42]
Vohora D, Pal SN, Pillai K. Modulation of spontaneous alternation performance of mice treated with thioperamide and tacrine in a cross maze task. Fundam Clin Pharmacol 2005; 19: 531-2.
[43]
Vohora D, Pal S, Pillai K. Effect of locomotor activity on the passive avoidance test for the evaluation of cognitive function. Int J Pharmacol 2000; 32: 242-5.
[44]
Pillai-Nair N, Panicker AK, Rodriguiz RM, et al. Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci 2005; 25: 4659-71.
[45]
Dębiec J, Ledoux J. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neurosci 2004; 129: 267-72.
[46]
Essman WB. Electroshock-induced retrograde amnesia in seizure-protected mice. Psychol Rep 1968; 22: 929-35.
[47]
Gozal D, Nair D, Goldbart AD. Physical activity attenuates intermittent hypoxia-induced spatial learning deficits and oxidative stress. Am Respir Critical Care Med 2010; 182: 104-12.
[48]
Narwal S, Negi RS. Behavior & pharmacological animal models for the evaluation of learning & memory condition. Indo Global J Pharm Sci 2010; 2: 121-9.
[49]
Gibson G, Blass J. Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 1976; 27: 37-42.
[50]
Dilts S, Berry C. Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exp Ther 1967; 158: 279-85.
[51]
Hock F. Effects of cromakalim on sodium nitrite intoxication.Gene, brain and behavior Proceeding of 21st Gottingen Neurobiology
Conference Stuttgart: George Thieme Verlag 1993; 681-6.
[52]
Hiramatsu M, Murasawa H, Nabeshima T, Kameyama T. Effects of U-50,488 H on scopolamine-, mecamylamine-and dizocilpine-induced learning and memory impairment in rats. J Pharmacol Exp Ther 1998; 284: 858-67.
[53]
Galeotti N, Bartolini A, Ghelardini C. Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behav Brain Res 2004; 153: 409-17.
[54]
Petit TL, Biederman GB, McMullen PA. Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Exp Neurol 1980; 67: 152-62.
[55]
Yamazaki M, Okabe M, Yamamoto N, Yarimizu J, Harada K. Novel 5-HT 5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats. J Pharmacol Sci 2015; 127: 362-9.
[56]
Schindler U, Rush D, Fielding S. Nootropic drugs: Animal models for studying effects on cognition. Drug Dev Res 1984; 4: 567-76.
[57]
Galeotti N, Bartolini A, Ghelardini C. Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behav Brain Res 2004; 153: 409-17.
[58]
Petit TL, Biederman GB, McMullen PA. Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: Implications for brain aging. Exp Neurol 1980; 67: 152-62.
[59]
Doeller CF, King JA, Burgess N. Parallel striatal and hippocampal systems for landmarks and boundaries in spatial memory. Proc Natl Acad Sci 2008; 105: 5915-20.
[60]
Barnes TD, Kubota Y, Hu D, Jin DZ, Graybiel AM. Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories. Nature 2005; 437: 1158.
[61]
Yin HH, Knowlton BJ. The role of the basal ganglia in habit formation. Nat Rev Neurosci 2006; 7: 464.
[62]
Iaria G, Petrides M, Dagher A, Pike B, Bohbot VD. Cognitive strategies dependent on the hippocampus and caudate nucleus in human navigation: Variability and change with practice. J Neurosci 2003; 23: 5945-52.
[63]
Wilson MA, McNaughton BL. Dynamics of the hippocampal ensemble code for space. Science 1993; 261: 1055-9.
[64]
Thompson L, Best P. Long-term stability of the place-field activity of single units recorded from the dorsal hippocampus of freely behaving rats. Brain Res 1990; 509: 299-308.
[65]
Rossato JI, Zinn CG, Furini C, et al. A link between the hippocampal and the striatal memory systems of the brain. An Acad Bras Cienc 2006; 78: 515-23.
[66]
Hartley T, Maguire EA, Spiers HJ, Burgess N. The well-worn route and the path less traveled: Distinct neural bases of route following and wayfinding in humans. Neuron 2003; 37: 877-88.
[67]
Morris RG, Moser E, Riedel G, et al. Elements of a neurobiological theory of the hippocampus: The role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci 2003; 358: 773-86.
[68]
Teather LA, Packard MG, Smith DE, Ellis-Behnke RG, Bazan NG. Differential induction of c-Jun and Fos-like proteins in rat hippocampus and dorsal striatum after training in two water maze tasks. Neurobiol Learn Mem 2005; 84: 75-84.
[69]
Packard MG, Cahill L, McGaugh JL. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc Natl Acad Sci 1994; 91: 8477-81.
[70]
Quevedo J, Vianna MR, Roesler R, et al. Pretraining but not preexposure to the task apparatus prevents the memory impairment induced by blockade of protein synthesis, PKA or MAP kinase in rats. Neurochem Res 2005; 30: 61-7.
[71]
Cammarota M, Bevilaqua L, Köhler C, Medina J, Izquierdo I. Learning twice is different from learning once and from learning more. Neuroscience 2005; 132: 273-9.
[72]
Cammarota M, Bevilaqua LR, Medina JH, Izquierdo I. Retrieval does not induce reconsolidation of inhibitory avoidance memory. Learn Mem 2004; 11: 572-8.
[73]
Nader K. Memory traces unbound. Trends Neurosci 2003; 26: 65-72.
[74]
Daumas S, Halley H, Francés B, Lassalle J-M. Encoding, consolidation, and retrieval of contextual memory: Differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn Mem 2005; 12: 375-82.
[75]
Gilmartin MR, McEchron MD. Single neurons in the dentate gyrus and CA1 of the hippocampus exhibit inverse patterns of encoding during trace fear conditioning. Behav Neurosci 2005; 119: 164.
[76]
Knight DC, Nguyen HT, Bandettini PA. The role of the human amygdala in the production of conditioned fear responses. Neuroimage 2005; 26: 1193-200.
[77]
Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 2004; 74: 301-20.
[78]
Buccafusco JJ. Methods of behavior analysis in neuroscience. Crc Press 2000.
[79]
Zameer S, Najmi AK, Vohora D, Akhtar M. Bisphosphonates: Future perspective for neurological disorders. Pharmacol Rep 2018; 70(5): 900-7.
[80]
van Dun K, Overwalle FV, Manto M, Marien P. Cognitive impact of cerebellar damage: Is there a future for cognitive rehabilitation? CNS Neurol Disord Drug Targets 2018; 17: 199-206.
[81]
Pan Z, Grovu RC, Cha DS, et al. Pharmacological treatment of cognitive symptoms in major depressive disorder. CNS Neurol Disord Drug Targets 2017; 16: 891-9.
[82]
Balea M, Muresanu D, Alvarez A, et al. VaD-An integrated framework for cognitive rehabilitation. CNS Neurol Disord Drug Targets 2018; 17: 22-33.
[83]
Martinelli I, Tomassoni D, Moruzzi M, Traini E, Amenta F, Khosrow TS. Obesity and metabolic syndrome affect the cholinergic transmission a nd cognitive functions. CNS Neurol Disord Drug Targets 2017; 16: 664-76.
[84]
Zameer S, Kaundal M, Vohora D, Ali J, Najmi AK, Akhtar M. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1. Neurotoxicol 2019; 70: 122-34.
[85]
Kamal MA, Shakil S, Nawaz MS, et al. Inhibition of butyrylcholinesterase with fluorobenzylcymserine, an experimental alzheimer’s drug candidate: Validation of enzoinformatics results by classical and innovative enzyme kinetic analyses. CNS Neurol Disord Drug Targets 2017; 16: 820-7.
[86]
Geng J, Wang L, Zhang L, et al. Blood-brain barrier disruption induced cognitive impairment is associated with increase of inflammatory cytokine. Front Aging Neurosci 2018; 10: 129.
[87]
Wei X, Xu Y, Jin Y, Feng H, Xiao Y, Dong S. Granulocyte colony-stimulating factor attenuates blood-brain barrier damage and improves cognitive function in spontaneously hypertensive rats. CNS Neurol Disord Drug Targets 2017; 16: 781-8.
